Skip to content

Cross-sectional survey of the correlation between granulomatous mastitis and mood and distribution of evidence elements in the acute phase of the disease

Cross-sectional survey of the correlation between granulomatous mastitis and mood and distribution of evidence elements in the acute phase of the disease

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077075
Enrollment
Unknown
Registered
2023-10-27
Start date
2023-10-31
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

granulomatous mastitis

Interventions

granulomatous mastitis group:non-intervention

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria (patient version) (1) Meet the diagnostic criteria for granulomatous mastitis (pathologic findings returned as granulomatous mastitis), as well as the clinical staging of GLM as acute, and subacute. (2) Females between the ages of 20 and 50 years (including 20 years 50 years), and within 8 years after delivery; (3) Those who signed informed consent. Inclusion criteria (healthy human version) (1) Women with non-mastitis (both lactating and non-lactating) or without breast disease or healthy women. (2) Women between the ages of 20-50 years (including 20 years 50 years), within 8 years after delivery; (3) Those who signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria (patient version) (1) Those with combined breast malignancy; (2) Excluding patients with confirmed diagnosis of anxiety or depression; (3) Combined with serious primary diseases such as cardiovascular, cerebrovascular, hepatic, renal and hematopoietic systems; (4) Women during pregnancy and lactation; (5) Those who are participating in other clinical studies. Exclusion criteria (healthy person version) (1) Those with combined breast malignant tumors; (2) Excluding patients diagnosed with anxiety or depression; (3) Combined with serious primary diseases such as cardiovascular, cerebrovascular, hepatic, renal and hematopoietic systems; (4) Women during pregnancy and lactation; (5) Those who are participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Localized Breast Signs;Evidence Scale;Generalized Anxiety Scale (GAD-7);

Secondary

MeasureTime frame
Depression Screening Scale (PHQ-9);Self-assessment scale for anxiety (SAS);Self-assessment scale for depression (SDS);

Countries

China

Contacts

Public ContactDongxiao Zhang

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, mammary gland department Beijing, China

1106453218@qq.com+86 138 1107 7684

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026